5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Ascierto, Paolo A.; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Atkinson, Victoria; Dutriaux, Caroline; Garbe, Claus; Hsu, Jessie; Jones, Surai; Li, Haocheng; McKenna, Edward; Voulgari, Athina; McArthur, Grant A.

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Autor(en):

Ascierto, Paolo A.; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Atkinson, Victoria; Dutriaux, Caroline; Garbe, Claus; Hsu, Jessie; Jones, Surai; Li, Haocheng; McKenna, Edward; Voulgari, Athina; McArthur, Grant A.

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

Clinical Cancer Research (2021), Bd. 27, H. 19, S. 5225-5235

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1078-0432.CCR-21-0809

ISSN:

1557-3265